Shaping regulatory complexity into strategic clarity

As AI continues to reshape healthcare, clear guidance on health data use is more critical than ever. Building on the success of the AI Act e-tool and the Data A...

Genovis i licensavtal med amerikansk partner – ”En stark bekräftelse”

Skånebaserade Genovis har ingått ett licensavtal som kan ge bolaget upp till 20 miljoner dollar för varje program som når kommersialisering.

ZEISS showcases expansion of ophthalmic care options creating industry-leading workflow solutions

ZEISS Medical Technology will showcase new ophthalmic innovations and market milestones at ESCRS 2025 in Copenhagen.

”Trickier than bacteria”: Why severe fungal infections are on the rise

There’s a reason Earth is sometimes called the planet of fungi. These ancient organisms – billions of years old and more closely related to animals than to plan...

New drug to simplify treatment of hemophilia

A new type of treatment for hemophilia, which only needs to be administered every two months, has been approved by the U.S. Food and Drug Administration (FDA).

ZEISS showcases comprehensive workflow for full spectrum of retina care at EURETINA

ZEISS Medical Technology combines its diagnostic, surgical and digital technologies to support healthcare professionals in advancing retinal care.

Product demo with features, software and best-practices

Get interesting insights about ZEISS O-INSPECT duo in our demo recording.

Roche har ny Sverige-vd

Den här veckan inleder Olalla Grau sitt arbete som högsta chef för Roche i Sverige.

Microscope or Measuring Machine? Both!

Watch our demo recording with features, software and best-practices.

New findings on the diseases that crushed Napoleon’s army

As if cold, starvation, and typhus weren’t enough. New research reveals that Napoleon’s defeated army also suffered from paratyphoid fever and relapsing fever d...

Swedish life science is growing – but capital is not keeping up

The number of employees and companies in Swedish life science is increasing and the sector is more equal than many other sectors. But investments in unlisted co...

Business Sweden: Skalbarhet avgör nästa fas för svensk ATMP

Avancerade terapiläkemedel (ATMP) är en svensk styrkegren, men när fältet nu mognar skiftar spelplanen. I nästa fas är det inte bara forskningen som står i foku...

Genmab drops another ADC candidate from billion‑dollar ProfoundBio deal

Danish biotech Genmab has discontinued development of its antibody‑drug conjugate (ADC) candidate GEN1160, citing low patient enrollment in an early‑stage cancer trial.

The vaccine has saved 94 million lives – but measles is spreading again

A disease we once believed belonged to the past is now resurging in both Europe and the United States. In the shadow of growing skepticism and declining vaccina...

Obesity dominates as future blockbusters are identified

Two drug candidates targeting obesity and diabetes stand out sharply in Clarivate’s newly selected “starting eleven” of potential future blockbusters worth watching.

Bioscience – Groundbreaking Research & Diagnostics: Stockholm

Lif:s vd får tung post i MVA

Lif:s vd Sofia Wallström har valts in till styrelsen och posten som ny vice ordförande i Medicon Valley Alliance, MVA. Samtidigt stärks den nordiska representat...

A cluster contribution to European life science innovation and competitiveness?

New moves around Nykode's management – withdrawal of resignations

Norwegian Nykode Therapeutics is reinstating members of the management team who previously announced their resignations.

Gene therapy restored hearing in children with congenital deafness

Eleven out of twelve children with congenital deafness showed improvements in a study testing Regeneron’s gene therapy for hereditary hearing loss. The U.S. com...

Top 10 biggest drug launches 2026

Two presumed sales rockets – both in obesity and type 2 diabetes – top a list of potential blockbusters expected to launch in the United States in 2026.

AI automates testing of implant coatings

The medical technology group Smith+Nephew uses an AI-supported light microscope ZEISS Axio Imager to inspect coated implants.

Swedish team tests Alzheimer antibody for brain imaging

Recent breakthroughs in Alzheimer’s treatment have increased the need for precise diagnostics in the field. Researchers in Uppsala are working to develop improv...

Asgard lär tumören ta kål på sig själv – närmar sig klinisk prövning

Lundbaserade Asgard Therapeutics har inte bara ett fantasieggande namn, utan även en sällsynt spännande approach till cancerbekämpning: att få tumörceller att p...